Promotion of wound healing using adipose-derived stem cells in radiation ulcer of a rat model
© Huang et al.; licensee BioMed Central Ltd. 2013
Received: 15 April 2013
Accepted: 19 July 2013
Published: 22 July 2013
Wound healing is a complex biologic process that involves the integration of inflammation, mitosis, angiogenesis, synthesis, and remodeling of the extracellular matrix. However, some wounds fail to heal properly and become chronic. Although some simulated chronic wound models have been established, an efficient approach to treat chronic wounds in animal models has not been determined. The aim of this study was to develop a modified rat model simulating the chronic wounds caused by clinical radiation ulcers and examine the treatment of chronic wounds with adipose-derived stem cells.
Sprague–Dawley rats were irradiated with an electron beam, and wounds were created. The rats received treatment with adipose-derived stem cells (ASCs), and a wound-healing assay was performed. The wound sizes after ASC treatment for 3 weeks were significantly smaller compared with the control condition (p < 0.01). Histological observations of the wound edge and immunoblot analysis of the re-epithelialization region both indicated that the treatment with ASCs was associated with the development of new blood vessels. Cell-tracking experiments showed that ASCs were colocalized with endothelial cell markers in ulcerated tissues.
We established a modified rat model of radiation-induced wounds and demonstrated that ASCs accelerate wound-healing.
KeywordsAdipose-derived stem cells Mesenchymal stem cells Radiation ulcer Wound model
Approximately 50% of cancer patients receive radiation as an adjuvant therapy . Although radiation therapy technology has progressed substantially, patients still suffer from various degrees of non-specific radiation damage to non-cancerous tissues . Radiation ulcers have posed a formidable challenge to reconstructive surgeons [3, 4]; they cause great distress to patients, impair their quality of life, and require enormous medical resources. These chronic wounds can last for several years, and some may even lead to amputation .
The mechanism of radiation injury is through damage to the DNA of cells, leading to cell apoptosis or necrosis. The histological features are vascular dilation and thrombosis, inflammation, and finally, hypovascular and fibrosis abscent of the epithelium and hair follicles. Radiation injury may cause redness, peeling, moist ulcers and other features depending on the severity. Ulcers may take several months to several years to heal .
Strategies for treating chronic wounds include the use of various growth factors [6–10], hyperbaric oxygen , and stem cells . Mesenchymal stem cells (MSCs) have been considered to be suitable for application to ischemic wounds [12–14]. Mesenchymal stem cells may be derived from the bone marrow, umbilical cords or fat. Adipose-derived stem cells (ASCs) are easily isolated in large quantities because they are easy to culture and amplify, such that they have more potential for use in treatment applications than other cell preparations . Extracts of uncultured fat applied to radiation skin ulcers and chronic lower extremity ulcers have been reported in clinical cases, and the wound-healing properties have been considered to be mediated by stem cells [16–18]. ASCs are considered to be suitable for the treatment of ischemic wounds because of their potential to differentiate into several cell types, such as endothelial cells, and secrete angiogenic and anti-apoptotic factors [19, 20]. ASCs accelerate wound healing in ischemic models, such as diabetes-impaired wounds or mitomycin C-treated wounds [21, 22]. The local delivery of ASCs via acellular matrix, such as an atelocollagen matrix, a silk fibroin-chitosan scaffold or acellular dermal matrix, has been considered a promising strategy to accelerate wound healing [22–24].
In this study, we attempted to establish a radiation-induced wound model and evaluate the effectiveness of in vitro cultured ASCs for the promotion of the wound healing of radiation ulcers via angiogenesis.
All of the animal experiments were approved and conducted under the guidance of the Institutional Animal Care and Use Committee (accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International), National Defense Medical Center, Taipei, Taiwan.
Isolation and culture of ASCs
Inguinal fat pads were harvested from 9- to 12-week-old Sprague–Dawley rats (BioLASCO, Taipei, Taiwan). The isolation and culture of ASCs were followed by our previous description . The cells were used for experiments at passages 4–6.
Mesenchymal stem cell immunophenotype
Cells from the fourth passage were analyzed for their immune phenotype. A total of 3 × 105 cells were resuspended in 200 μl PBS containing 0.5% bovine serum albumin and incubated for 30 min at 4°C with monoclonal antibodies against rat CD29-fluorescein isothiocyanate (FITC) (BD Pharmingen, CA, USA), CD34-FITC (Santa Cruz Biotechnology, CA, USA), CD45-FITC (BD Pharmingen), CD90-FITC (BD Pharmingen), CD73 (mouse anti-rat; 5 F/B9, BD Pharmingen), CD31 (ab64543) or vWF (von Willebrand factor) (ab6994) (Abcam, Cambridge, UK) or the respective isotype control. For the detection of CD73, goat anti-mouse Alex Flour 488 (Invitrogen) was used for another round of incubation after PBS washing and resuspension in PBS containing 0.5% bovine serum albumin (Bio-Rad Laboratories, CA, USA). The cells were analyzed with a FACSCalibur cytometer (Becton Dickinson, NJ, USA) and this procedure has been described previously .
ASC Differentiation Assays
Putative ASCs were incubated to differentiate into adipocytes and osteoblasts, described previously . For adipocyte differentiation, cells reaching confluence were incubated for 7 repetitive cycles of 48 hours in adipogenic differentiation medium. For osteocyte differentiation, cells reaching confluence were cultured with osteogenic medium for 2 weeks. Oil red O (Sigma) and Alizarin red S (Sigma) dyes were used to identify adipocytes and osteoblasts, respectively.
The total RNA of cultured cells at the indicated passage number was extracted with Tri Reagent (Ambion, TX, USA). cDNA was synthesized using Superscript III reverse transcriptase (Invitrogen, company location needed). Real-time PCR analysis was performed with a 7500 Real-time PCR system (Applied Biosystems, CA, USA) using Power SyBr Green PCR master mix (Applied Biosystems) with the following primers: VEGF sense, AGGCTGCACCCACGACAGAA; VEGF anti-sense, CTGGAAGATGTCCACCAGGG; HGF sense, TTTGGCCATGAATTTGACCTCT; HGF anti-sense, CTTCTGAACACTGAGGAATGTC; GAPDH sense, TCCTGCACCACCAACTGC; and GAPDH anti-sense, GCCATCCACAGTCTTCTG. GAPDH was used as an endogenous reference in each case. The data are presented as the average of triplicate experiments ± the standard error of the mean (SEM).
Rat ASCs isolated from three different rats were respectively cultured and expanded in culture medium (DMEM-10% FBS). At 70-90% confluence, cells were detached and passaged at a ratio of 1:3 at indicated passage numbers. After 24 hours incubation in culture medium, cells were switched to DMEM-5% FBS and incubated for 72 hours. Then, the condition medium was collected, and cell numbers were determined by trypan blue exclusion. The concentrations of vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) were measured using sandwich ELISA kit according to the manufacturer’s instruction: Rat VEGF Immunoassay and mouse/rat HGF Immunoassay kits were obtained from R&D Systems (Minneapolis, MN, USA). Data are presented as pictograms of the secreted factor per 104 cells at the time of harvest.
Wound model and wound-healing assay
Eight-week-old male rats weighing 250–300 g were used in this study. After anesthesia with Zoletil 50 (0.1 ml/100 g) (Virbac, Paris, France) and shaving the wool of the dorsum, four rats were irradiated with an electron beam (Primus, Erlangen, Germany) operated at 6 MeV. The dose rate was 900 cGy/min. A single dose of 50 Gy was given through an area of 3 cm diameter marked on the dorsal skin, and the surrounding healthy tissue was protected by a 1.2 cm lead shield. The assessment of acute skin reactions with a visual skin score began eleven days after radiation and was continued every two days until the 57th day after irradiation. The score was based on a previously described scoring method .
0 = normal;
0.25 = transient erythema, edema, or dry desquamation on dorsum or sole of the foot;
0.5 = slight epilation in <50% of exposure area;
1.0 = epilation in about 50% of exposure area;
1.5 = epilation in >50% of exposure area or some signs of dry desquamation on the leg; 2.0 = complete epilation, red foot, or dry desquamation in ≤50% of exposure area with epilation in ≥50% of exposure area;
2.5 = complete epilation with definite edema or dry desquamation in >50% area;
3.0 = moist desquamation in a small area; and
3.5 = moist desquamation in most of the area.
An additional three rats were irradiated with a 50 Gy electron beam, and the wound tissues were removed at the first, second and third weeks for histological observations of the wound model. Normal skin was removed from a healthy rat as a comparison.
To evaluate the wound size, the ulcerated area of each rat was recorded with a SANYO Xacti VPC-CA65 digital camera at weeks 3, 4, 5 and 6 post-radiation. Images were analyzed with Image-Pro Plus software. Discriminations between the ulcer and the re-epithelialization of the skin were performed by two investigators who were blind to group assignments.
ASC transplantation and tracking
Three weeks after radiation, the rats were anesthetized, randomly divided into two groups (n = 8 each group), and injected with either 1 × 106 ASCs resuspended in 0.8 ml of PBS (experiment group) or 0.8 ml PBS (control group) into the wound bed and margin. The two groups were treated with ASCs (experiment group) and PBS (control group) for four and five weeks post-radiation. The experiments ended at week 6 post-radiation, and the skin, including the wounds, was removed from each rat for histological examination, immunoblot analysis, vessel density assessment and dermal thickness measurement. Beside the animals used for the characterization of wound model and evaluation of ASCs treatment described previously, two additional rats were irradiated for tracing the transplanted ASCs in the ulcerated tissue described below.
The fourth-passage ASCs were labeled with 20 μM fluorescent cell tracker CM-DiI (chloromethyl-benzamido derivative of 1,1′-dioctadecyl-3,3,3′3′-tetra- methyl-inodcarbocyanine) (Molecular Probes, OR, USA) in accordance with the manufacturer’s recommendations. The procedure has been described previously .
Histological examination and immunostaining
The removed skin, including the ulcers and re-epithelialized tissue, was fixed in 10% formalin for at least 24 h, embedded in paraffin, and sectioned in 5 μm increments. Frozen sections were prepared for the immunostaining of CD31 (ab64543) or vWF (ab6994) (Abcam, Cambridge, UK). For the staining of vWF, the tissues were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. For the staining of CD31, the tissues were fixed with 4% paraformaldehyde. Morphological observations were described previously .
Skin samples were homogenized in lysis buffer (100 mM Tris–HCl, pH 8.0, 150 mM NaCl, 0.1% SDS, and 1% Triton 100) at 4°C. The cell extracts were separated through sodium dodecyl sulfate-polyacrylamide gel electrophoresis, transferred onto a polyvinylidene difluoride membrane (Millipore, MA, USA) and detected using antibodies against CD31 (TLD-3A12, BD Pharmingen) and Hu Antigen R (HuR) (3A2; Santa Cruz Biotechnology) as a control.
Vessel density assessment
Three weeks after starting the treatment, wound tissues of ASC-treated or control group were removed and made into 8 μm frozen sections. After the staining of CD31 and DAPI, the blood vessel density of each wound was calculated and described as follows: for each wound (n = 8), five non-consecutive tissue sections were made. For each section, three randomly selected fields (400× magnification) of ulcer tissues were photographed by fluorescence microscopy (Leica, Wetzlar, Germany). A total of 15 images were taken for each wound, and neo-vasculation was assessed by measuring the CD31 stained capillaries.
Dermal thickness measurement
Dermal thickness was measured in eight animals from each group and normal skin as the control. A representative image of H&E-stained sections was obtained. The dermal thickness was measured at three points in each image.
All of the data were calculated as the mean ± SEM. Statistical analyses were performed using a two-tailed Student t test. Significant differences were defined by p < 0.05.
Characterization of rat ASCs
The establishment of a wound model of acute radiation skin ulcers
Histological observation showed the characteristics of radiation ulcers on skin. The dermis of normal skin on the control rats contained hair follicles (Figure 3B). One week (score = 0) after irradiation, vascular dilution and thrombosis were clearly observed (Figure 3C, indicated as arrows), although the epidermis had not yet fallen off. Day14 (score around 2.5) and day 21 (score around 3) after irradiation, fibrosis and a lack of epithelium and follicles in the tissue were observed (Figure 3D and E) as previously described . More importantly, the weight of all of the rats continued to increase after radiation (data not shown), suggesting that radiation injury did not cause life-threatening stress to the rats. Therefore, we had established a model of acute skin radiation injury.
Transplantation of ASCs could enhance wound healing
Transplantation of ASCs increased angiogenesis and granulation in wound healing
Tracking of CM-DiI-labeled ASCs after transplantation
As an adjuvant therapy for cancer, Siemens Primus produces electron or photon radiation for use on the surface layer of the skin or for deep tissue damage, respectively. In this study, we used electron beam radiation to simulate skin damage during cancer treatment. Approximately one week later, the skin began to deteriorate in appearance; the wound gradually showed edema and epilation and eventually showed moist desquamation in the exposure area (Figure 3, days 14–21). These histological observations are consistent with the characteristics of radiation ulcers. Therefore, we did develop a modified rat model of acute radiation skin damage for chronic wounds in this study. In contrast with previous models (combined radiation–wound or leg ulcers caused by radiation) [28, 29], our model more closely simulates the chronic wounds caused by clinical radiation ulcers and can provide more adequate tissue for observation and biochemical analysis.
Isolated ASCs may contain several cell types, including endothelial cells, smooth muscle cells, pericytes, fibroblasts, and preadipocytes . With the increase in passage numbers, cells gradually present a more homogeneous cell population . Although ASCs can differentiate into various cell types, such as adipocytes and osteocytes in this study, these capabilities may vary with the cell culture environment and passage number. For example, studies have shown that ASCs can differentiate into myocardial cells in primary cell culture but not in later generations of cells . To achieve the best applications for different purposes, culture conditions, passage number and other factors that may affect cell ability are worthy of more detailed study in the future. In this study, the results of real-time PCR and ELISA analysis indicated that the mRNA and secretory protein expressions of VEGF and HGF in ASCs showed an increasing trend with increasing passage number. The expression level reached a peak at approximately the 4th-6th generations of ASCs. Therefore, we chose the 4th generation of ASCs for subsequent experiments. It is a puzzle to demonstrate paracrine effects and/or direct ASC effects, however, both effects are supported by previous studies [20, 21].
Clinical cases of the application of processed lipoaspirate (PLA) cells in radiation ulcer treatment indicate that isolated ASCs within PLA cells may play a key role in wound healing . We further demonstrated that the allogeneic transplantation of in vitro cultured ASCs enhanced the healing of radiation ulcers. The results of cell-tracking experiments, histological examination, and immunoblot analysis indicate that ASCs could increase the blood supply and granulation rate in wound healing. In addition, cell-tracking experiments also showed that ASCs could survive (14 days) and proliferate in the ulcers (data not shown), suggesting that these cells create long-term effects in ulcers. Consistent with previous studies, our results indicate that transplanted ASCs colocalized with endothelial markers [24, 33]. However, these data are not enough to conclude that ASCs differentiated into endothelial cells because the colocalization of these signals may be due to cell fusion between transplanted ASCs and endothelial cells of the host. To address this question, heterograft experiments combined with species-specific antibody examination should be carried out in the future.
Strategies for treating chronic wounds include various growth factors [6–10], hyperbaric oxygen , and stem cells [8, 10]. MSCs have been considered suitable for application to ischemic wounds [12–14]. MSCs may come from bone marrow, umbilical cords or fat. ASCs are easily isolated in large quantities, being easy to culture and amplify, and therefore have more potential for treatment applications . Extracts of uncultured fat applied to radiation skin ulcers and chronic lower-extremity ulcers have been reported in clinical cases, and it is considered that the wound-healing properties come from stem cells [16–18]. ASCs are considered suitable for the treatment of ischemic wounds because of their potential for secretion of angiogenic and anti-apoptotic factors, and differentiation into several cell types such as endothelial cells [19, 20]. ASCs accelerate wound healing in ischemic models such as diabetes-impaired wounds or mitomycin C-treated wounds have been reported [21, 22]. Local delivery of ASCs via acellular matrix such as silk fibroin-chitosan scaffold, atelocollagen matrixwas or acellular dermal matrix has been considered a promising strategy to accelerated wound healing [22–24]. Previous studies have shown that bone marrow-derived MSCs that express human platelet-derived growth factor A and human beta-defensin 2 promote wound healing , and such a strategy may apply to our ASC treatment of radiation ulcers.
In the future, more effort will be required to improve the use of ASCs in the treatment of radiation injuries. In this study, we injected ASCs into the site of the radiation wound. However, cells injected into the wound bed did not spread evenly but clustered at the location of the injection. To overcome this obstacle, ASC therapy through ASC-seeded scaffolds [15, 34] or monolayer stem cells  may be applied. In future clinical applications, patients with local radiation injuries may use ASCs from non-irradiated sites and those with systemic radiation injuries may use ASCs or adipose tissue from ‘stockpiles’ or ‘banks’ for treatment .
We established a rat model of acute radiation ulcers and demonstrated that the allograft transplantation of in vitro cultured ASCs improved the wound healing of radiation ulcers. The histological examination of the wound edge and the immunoblot analysis of the re-epithelialization region both indicated that ASCs contributed directly to vascularization by acting as angiogenesis-promoting cells and/or likely by differentiating into endothelial cells. In the future, a better understanding of the impact of ASCs on ulcers and improvements in the technology of ASC treatment and storage will contribute to more effective ASC therapy for radiation ulcers and other chronic wounds.
Mesenchymal stem cells
Adipose-derived stem cells
von Willebrand factor
Vascular endothelial growth factor
Hepatocyte growth factor
Chloromethyl-benzamido derivative of 1,1′-dioctadecyl-3,3,3′3′-tetra- methyl-inodcarbocyanine.
We thank Department of Radiation Oncology, Tri-Service General Hospital, for a double-proton linear accelerator (Primus, Siemens, Erlangen, Germany). This work was supported by grants from the Tri-Service General Hospital [TSGH-C101-008-013-S01-14–to SG Chen and TSGH-C100-013-S04-09–to JYH Chan], Taiwan, ROC.
Part of this work had been presented at the Annual Meeting of the Taiwan Surgical Association, March 20, 2011, Taipei, Taiwan, ROC.
- Mendelsohn FA, Divino CM, Reis ED, Kerstein MD: Wound care after radiation therapy. Adv Skin Wound Care. 2002, 15: 216-224. 10.1097/00129334-200209000-00007.View ArticlePubMedGoogle Scholar
- Devalia HL, Mansfield L: Radiotherapy and wound healing. Int Wound J. 2008, 5: 40-44.View ArticlePubMedGoogle Scholar
- Olascoaga A, Vilar-Compte D, Poitevin-Chacon A, Contreras-Ruiz J: Wound healing in radiated skin: pathophysiology and treatment options. Int Wound J. 2008, 5: 246-257. 10.1111/j.1742-481X.2008.00436.x.View ArticlePubMedGoogle Scholar
- Cullum N, Nelson EA, Flemming K, Sheldon T: Systematic reviews of wound care management: (5) beds; (6) compression; (7) laser therapy, therapeutic ultrasound, electrotherapy and electromagnetic therapy. Health Technol Assess. 2001, 5: 1-221.View ArticlePubMedGoogle Scholar
- Feldmeier JJ, Heimbach RD, Davolt DA, McDonough MJ, Stegmann BJ, Sheffield PJ: Hyperbaric oxygen in the treatment of delayed radiation injuries of the extremities. Undersea Hyperb Med. 2000, 27: 15-19.PubMedGoogle Scholar
- Li J, Chen J, Kirsner R: Pathophysiology of acute wound healing. Clin Dermatol. 2007, 25: 9-18. 10.1016/j.clindermatol.2006.09.007.View ArticlePubMedGoogle Scholar
- Cha J, Falanga V: Stem cells in cutaneous wound healing. Clin Dermatol. 2007, 25: 73-78. 10.1016/j.clindermatol.2006.10.002.View ArticlePubMedGoogle Scholar
- Goldman R: Growth factors and chronic wound healing: past, present, and future. Adv Skin Wound Care. 2004, 17: 24-35. 10.1097/00129334-200401000-00012.View ArticlePubMedGoogle Scholar
- Efron PA, Moldawer LL: Cytokines and wound healing: the role of cytokine and anticytokine therapy in the repair response. J Burn Care Rehabil. 2004, 25: 149-160. 10.1097/01.BCR.0000111766.97335.34.View ArticlePubMedGoogle Scholar
- Brissett AE, Hom DB: The effects of tissue sealants, platelet gels, and growth factors on wound healing. Curr Opin Otolaryngol Head Neck Surg. 2003, 11: 245-250. 10.1097/00020840-200308000-00005.View ArticlePubMedGoogle Scholar
- Kranke P, Bennett M, Roeckl-Wiedmann I, Debus S: Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2004, 2: CD004123-PubMedGoogle Scholar
- Luo G, Cheng W, He W, Wang X, Tan J, Fitzgerald M, Li X, Wu J: Promotion of cutaneous wound healing by local application of mesenchymal stem cells derived from human umbilical cord blood. Wound Repair Regen. 2010, 18: 506-513. 10.1111/j.1524-475X.2010.00616.x.View ArticlePubMedGoogle Scholar
- Wu Y, Wang J, Scott PG, Tredget EE: Bone marrow-derived stem cells in wound healing: a review. Wound Repair Regen. 2007, 15 (Suppl 1): S18-S26.View ArticlePubMedGoogle Scholar
- Fu X, Fang L, Li X, Cheng B, Sheng Z: Enhanced wound-healing quality with bone marrow mesenchymal stem cells autografting after skin injury. Wound Repair Regen. 2006, 14: 325-335. 10.1111/j.1743-6109.2006.00128.x.View ArticlePubMedGoogle Scholar
- Sterodimas A, De Faria J, Nicaretta B, Pitanguy I: Tissue engineering with adipose-derived stem cells (ADSCs): current and future applications. J Plast Reconstr Aesthet Surg. 2010, 63: 1886-1892. 10.1016/j.bjps.2009.10.028.View ArticlePubMedGoogle Scholar
- Cervelli V, Gentile P, Grimaldi M: Regenerative surgery: use of fat grafting combined with platelet-rich plasma for chronic lower-extremity ulcers. Aesthetic Plast Surg. 2009, 33: 340-345. 10.1007/s00266-008-9302-z.View ArticlePubMedGoogle Scholar
- Chan CW, McCulley SJ, Macmillan RD: Autologous fat transfer–a review of the literature with a focus on breast cancer surgery. J Plast Reconstr Aesthet Surg. 2008, 61: 1438-1448. 10.1016/j.bjps.2008.08.006.View ArticlePubMedGoogle Scholar
- Rigotti G, Marchi A, Galie M, Baroni G, Benati D, Krampera M, Pasini A, Sbarbati A: Clinical treatment of radiotherapy tissue damage by lipoaspirate transplant: a healing process mediated by adipose-derived adult stem cells. Plast Reconstr Surg. 2007, 119: 1409-1422. 10.1097/01.prs.0000256047.47909.71. discussion 1423–1404View ArticlePubMedGoogle Scholar
- Schaffler A, Buchler C: Concise review: adipose tissue-derived stromal cells–basic and clinical implications for novel cell-based therapies. Stem Cells. 2007, 25: 818-827. 10.1634/stemcells.2006-0589.View ArticlePubMedGoogle Scholar
- Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV, March KL: Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004, 109: 1292-1298. 10.1161/01.CIR.0000121425.42966.F1.View ArticlePubMedGoogle Scholar
- Nie C, Yang D, Xu J, Si Z, Jin X, Zhang J: Locally administered adipose-derived stem cells accelerate wound healing through differentiation and vasculogenesis. Cell Transplant. 2011, 20: 205-216. 10.3727/096368910X520065.View ArticlePubMedGoogle Scholar
- Nambu M, Ishihara M, Nakamura S, Mizuno H, Yanagibayashi S, Kanatani Y, Hattori H, Takase B, Ishizuka T, Kishimoto S, 15: Enhanced healing of mitomycin C-treated wounds in rats using inbred adipose tissue-derived stromal cells within an atelocollagen matrix. Wound Repair Regen. 2007, 15: 505-510. 10.1111/j.1524-475X.2007.00258.x.View ArticlePubMedGoogle Scholar
- Altman AM, Yan Y, Matthias N, Bai X, Rios C, Mathur AB, Song YH, Alt EU: IFATS collection: Human adipose-derived stem cells seeded on a silk fibroin-chitosan scaffold enhance wound repair in a murine soft tissue injury model. Stem Cells. 2009, 27: 250-258. 10.1634/stemcells.2008-0178.View ArticlePubMedGoogle Scholar
- Huang SP, Hsu CC, Chang SC, Wang CH, Deng SC, Dai NT, Chen TM, Chan JY, Chen SG, Huang SM: Adipose-derived stem cells seeded on acellular dermal matrix grafts enhance wound healing in a murine model of a full-thickness defect. Ann Plast Surg. 2012, 69: 656-662. 10.1097/SAP.0b013e318273f909.View ArticlePubMedGoogle Scholar
- Moriyasu S, Yamamoto K, Kureyama N, Okamura K, Ikeda T, Yamatodani A: Involvement of histamine released from mast cells in acute radiation dermatitis in mice. J Pharmacol Sci. 2007, 104: 187-190. 10.1254/jphs.SC0070127.View ArticlePubMedGoogle Scholar
- Doring A, Wild M, Vestweber D, Deutsch U, Engelhardt B: E- and P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice. J Immunol. 2007, 179: 8470-8479.View ArticlePubMedGoogle Scholar
- Giddings JC, Shall L: Enhanced release of von Willebrand factor by human endothelial cells in culture in the presence of phorbol myristate acetate and interleukin 1. Thromb Res. 1987, 47: 259-267. 10.1016/0049-3848(87)90139-3.View ArticlePubMedGoogle Scholar
- Hao L, Wang J, Zou Z, Yan G, Dong S, Deng J, Ran X, Feng Y, Luo C, Wang Y, Cheng T: Transplantation of BMSCs expressing hPDGF-A/hBD2 promotes wound healing in rats with combined radiation-wound injury. Gene Ther. 2009, 16: 34-42. 10.1038/gt.2008.133.View ArticlePubMedGoogle Scholar
- Xiao Z, Su Y, Yang S, Yin L, Wang W, Yi Y, Fenton BM, Zhang L, Okunieff P: Protective effect of esculentoside A on radiation-induced dermatitis and fibrosis. Int J Radiat Oncol Biol Phys. 2006, 65: 882-889. 10.1016/j.ijrobp.2006.01.031.View ArticlePubMedGoogle Scholar
- Locke M, Windsor J, Dunbar PR: Human adipose-derived stem cells: isolation, characterization and applications in surgery. ANZ J Surg. 2009, 79: 235-244. 10.1111/j.1445-2197.2009.04852.x.View ArticlePubMedGoogle Scholar
- Yoshimura K, Shigeura T, Matsumoto D, Sato T, Takaki Y, Aiba-Kojima E, Sato K, Inoue K, Nagase T, Koshima I, Gonda K: Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J Cell Physiol. 2006, 208: 64-76. 10.1002/jcp.20636.View ArticlePubMedGoogle Scholar
- Planat-Benard V, Menard C, Andre M, Puceat M, Perez A, Garcia-Verdugo JM, Penicaud L, Casteilla L: Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res. 2004, 94: 223-229. 10.1161/01.RES.0000109792.43271.47.View ArticlePubMedGoogle Scholar
- Traktuev DO, Prater DN, Merfeld-Clauss S, Sanjeevaiah AR, Saadatzadeh MR, Murphy M, Johnstone BH, Ingram DA, March KL: Robust functional vascular network formation in vivo by cooperation of adipose progenitor and endothelial cells. Circ Res. 2009, 104: 1410-1420. 10.1161/CIRCRESAHA.108.190926.View ArticlePubMedGoogle Scholar
- Altman AM, Matthias N, Yan Y, Song YH, Bai X, Chiu ES, Slakey DP, Alt EU: Dermal matrix as a carrier for in vivo delivery of human adipose-derived stem cells. Biomaterials. 2008, 29: 1431-1442. 10.1016/j.biomaterials.2007.11.026.View ArticlePubMedGoogle Scholar
- Akita S, Akino K, Hirano A, Ohtsuru A, Yamashita S: Mesenchymal stem cell therapy for cutaneous radiation syndrome. Health Phys. 2010, 98: 858-862. 10.1097/HP.0b013e3181d3d52c.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.